Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.05% Cyclosporine for Mild to Moderate Dry Eye
NCT06981104Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cyclosporine 2% ophthalmic solution in dry eye disease (DED) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Fluorescent Tear Film Breakup Time at 8 weeks, High-Frequency Component at 8 weeks and 1 more. Started Nov 2024; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06981104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06981104.